Form 4: Pressure BioSciences CEO Acquires Shares Through Interest Payment
SEC Form 4 Filing
Richard T. Schumacher, President and CEO of Pressure BioSciences Inc, acquired 4,554 shares of common stock on March 27, 2024, through interest paid on convertible preferred stock.
Summary
- Richard T. Schumacher, the President and CEO of Pressure BioSciences Inc (PBIO), acquired 4,554 shares of common stock on March 27, 2024.
- The acquisition was a result of interest paid on convertible preferred stock.
- The price per share was $0.16.
- Following the transaction, Schumacher directly owns 60,089 shares of PBIO common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider activity. The acquisition of shares through interest payment doesn't necessarily indicate a positive or negative outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It's important to monitor such filings to understand management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it's a routine disclosure of insider activity.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of transaction: Richard T. Schumacher acquired 4,554 shares of common stock. |
| 03/28/2024 | Date of signature on the Form 4 filing. |
Keywords
Pressure BioSciences Inc, PBIO, Richard T. Schumacher, Insider Trading, Form 4, Beneficial Ownership, Common Stock, Convertible Preferred Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.